Inflammatory cell proliferation and inflammatory response pathways

Inflammatory cell proliferation and inflammatory response pathways refer to the integrated biological processes that govern the activation, expansion, and effector functions of immune cells in response to stimuli (Medzhitov, 2008). This term does not describe a single molecular target but rather a broad set of signaling cascades, including the NF-κB, JAK/STAT, and MAPK pathways, which regulate the expression of cytokines, chemokines, and adhesion molecules (Liu et al., 2017). In a healthy state, these pathways are essential for wound healing and pathogen clearance; however, their chronic dysregulation leads to tissue damage and is a hallmark of autoimmune diseases like rheumatoid arthritis and inflammatory bowel disease (O'Shea & Plenge, 2012). Therapeutic intervention typically involves targeting specific proteins within these pathways, such as kinases or receptors, to modulate the overall inflammatory response. Because these pathways are critical for host defense, their systemic inhibition can lead to significant safety concerns, including an increased susceptibility to opportunistic infections and impaired immune surveillance. Common drugs targeting components of these pathways include JAK inhibitors and monoclonal antibodies against specific cytokines. Monitoring efficacy often involves measuring systemic biomarkers like C-reactive protein or specific cytokine levels.

Other names

Inflammatory signaling pathwaysPro-inflammatory responseLeukocyte proliferation pathwaysInflammatory cascades

Inhibition of intracellular signaling cascades and cytokine-mediated activation of immune cells.